688767 Stock Overview
Engages in the research and development, manufacture, sale, and service of in vitro diagnostic assays and reagents, and instruments in China and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 0/6 |
| Past Performance | 4/6 |
| Financial Health | 6/6 |
| Dividends | 2/6 |
Community vs My Fair Value
Create NarrativeSelect a narrative for quick price alerts from the community, or create your own.
Hangzhou Biotest Biotech Co.,Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥38.90 |
| 52 Week High | CN¥39.38 |
| 52 Week Low | CN¥22.85 |
| Beta | 0.48 |
| 1 Month Change | 13.61% |
| 3 Month Change | 15.09% |
| 1 Year Change | 46.13% |
| 3 Year Change | -56.82% |
| 5 Year Change | n/a |
| Change since IPO | -49.57% |
Recent News & Updates
Shareholder Returns
| 688767 | CN Biotechs | CN Market | |
|---|---|---|---|
| 7D | 4.6% | 2.1% | 1.2% |
| 1Y | 46.1% | -12.4% | 12.5% |
Return vs Industry: 688767 exceeded the CN Biotechs industry which returned -12.4% over the past year.
Return vs Market: 688767 exceeded the CN Market which returned 12.5% over the past year.
Price Volatility
| 688767 volatility | |
|---|---|
| 688767 Average Weekly Movement | 4.3% |
| Biotechs Industry Average Movement | 5.1% |
| Market Average Movement | 6.0% |
| 10% most volatile stocks in CN Market | 10.2% |
| 10% least volatile stocks in CN Market | 3.4% |
Stable Share Price: 688767 has not had significant price volatility in the past 3 months compared to the CN market.
Volatility Over Time: 688767's weekly volatility (4%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2008 | 611 | Shujiang Wu | www.biotests.com.cn |
Hangzhou Biotest Biotech Co.,Ltd. engages in the research and development, manufacture, sale, and service of in vitro diagnostic assays and reagents, and instruments in China and internationally. The company offers medical test products for fertility health, cardiology, oncology, inflammation, biochemistry, and various infectious diseases.
Hangzhou Biotest Biotech Co.,Ltd. Fundamentals Summary
| 688767 fundamental statistics | |
|---|---|
| Market cap | CN¥4.07b |
| Earnings (TTM) | CN¥176.68m |
| Revenue (TTM) | CN¥560.59m |
23.0x
P/E Ratio7.3x
P/S RatioIs 688767 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 688767 income statement (TTM) | |
|---|---|
| Revenue | CN¥560.59m |
| Cost of Revenue | CN¥0 |
| Gross Profit | CN¥560.59m |
| Other Expenses | CN¥383.90m |
| Earnings | CN¥176.68m |
Last Reported Earnings
Dec 31, 2024
Next Earnings Date
Apr 26, 2025
| Earnings per share (EPS) | 1.69 |
| Gross Margin | 100.00% |
| Net Profit Margin | 31.52% |
| Debt/Equity Ratio | 0.03% |
How did 688767 perform over the long term?
See historical performance and comparisonDividends
2.6%
Current Dividend Yield132%
Payout RatioCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/03/20 13:58 |
| End of Day Share Price | 2025/03/20 00:00 |
| Earnings | 2024/12/31 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Hangzhou Biotest Biotech Co.,Ltd. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.